Access
To read this story in full you will need to login or make a payment (see right).
Article
Nature 443, 180-185 (14 September 2006) | doi:10.1038/nature05155; Received 9 May 2006; Accepted 11 August 2006; Published online 30 August 2006
Open Innovation Challenges
-
Optimizing Sub-cellular Localization Tags
The Seeker is looking for methods to optimize sub-cellular localization tags for protein expression....
-
Novel Approaches to Protecting Maize from Insect Damage
The Seeker is looking for novel approaches to protecting maize from insect damage. This Challenge re...
nature jobs
Assistant Professor
- University of Texas
- Austin TX United States
Instrumentation Engineer
- Praj Matrix - Praj Industries Ltd
- Pune, Maharashtra Pune-411021 India
Structure of a bacterial multidrug ABC transporter
Roger J. P. Dawson1 & Kaspar P. Locher1
- Institute of Molecular Biology and Biophysics, ETH Zurich, 8093 Zurich, Switzerland
Correspondence to: Kaspar P. Locher1 Correspondence and requests for materials should be addressed to K.P.L. (Email: kaspar.locher@mol.biol.ethz.ch). Coordinates and structure factors for Sav1866 have been deposited in the Protein Data Bank under the accession code 2HYD.
Abstract
Multidrug transporters of the ABC family facilitate the export of diverse cytotoxic drugs across cell membranes. This is clinically relevant, as tumour cells may become resistant to agents used in chemotherapy. To understand the molecular basis of this process, we have determined the 3.0 Å crystal structure of a bacterial ABC transporter (Sav1866) from Staphylococcus aureus. The homodimeric protein consists of 12 transmembrane helices in an arrangement that is consistent with cross-linking studies and electron microscopic imaging of the human multidrug resistance protein MDR1, but critically different from that reported for the bacterial lipid flippase MsbA. The observed, outward-facing conformation reflects the ATP-bound state, with the two nucleotide-binding domains in close contact and the two transmembrane domains forming a central cavity—presumably the drug translocation pathway—that is shielded from the inner leaflet of the lipid bilayer and from the cytoplasm, but exposed to the outer leaflet and the extracellular space.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
The ABCs of trans(porter) inhibitionNature Chemical Biology News and Views (01 Aug 2008)
A snapshot of Nature's favorite pumpNature Structural Biology News and Views (01 Nov 2001)
See all 5 matches for News And ViewsRESEARCH
Crystal structure of a catalytic intermediate of the maltose transporterNature Article (22 Nov 2007)
See all 50 matches for Research
